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Timely and accurate assembly of the mitotic spindle
is critical for the faithful segregation of chromo-
somes, and centrosome separation is a key step in
this process. The timing of centrosome separation
varies dramatically between cell types; however,
the mechanisms responsible for these differences
and its significance are unclear. Here, we show that
activation of epidermal growth factor receptor
(EGFR) signaling determines the timing of centro-
some separation. Premature separation of centro-
somes decreases the requirement for the major
mitotic kinesin Eg5 for spindle assembly, accelerates
mitosis, and decreases the rate of chromosome mis-
segregation. Importantly, EGF stimulation impacts
upon centrosome separation and mitotic progres-
sion to different degrees in different cell lines. Cells
with high EGFR levels fail to arrest in mitosis upon
Eg5 inhibition. This has important implications for
cancer therapy because cells with high centrosomal
response to EGF aremore susceptible to combinato-
rial inhibition of EGFR and Eg5.
INTRODUCTION
A critical event during mitosis is the assembly of the bipolar spin-
dle. The mitotic spindle comprises two microtubule organizing
centers (centrosomes), microtubules and kinetochores (Walczak
and Heald, 2008). During spindle assembly, centrosomes orga-
nize microtubules that either interdigitate or attach to kineto-
chores (Tanenbaum and Medema, 2010). One of the earliest
events during spindle assembly is the resolution of the centro-
somal linker that holds the two centrosomes together during
interphase. This can occur by one of two redundant pathways
(Bruinsma et al., 2012; Mardin and Schiebel, 2012). First, the
Mst2-hSav1-Nek2A module promotes the accumulation of
Nek2A kinase at the centrosomes. Nek2A then phosphorylates
the centrosomal linker proteins, C-Nap1 and rootletin, therebyDeveinducing the dissolution of the linker. Second, the kinesin-5
motor protein Eg5 slides antiparallel microtubules apart creating
a force that is able to separate the centrosomes even when the
Mst2-hSav1-Nek2A pathway is impaired (Mardin et al., 2010).
In addition to these two pathways, the timing of centrosome
separation was suggested to be differentially regulated relative
to nuclear envelope breakdown. In different cells, centrosome
separation occurs either via the prometaphase pathway that
depends on kinetochore generated forces or the prophase
pathway that is independent of the kinetochores (McHedlishvili
et al., 2012; Toso et al., 2009).
The motor protein Eg5 is important for bipolar spindle assem-
bly and spindle elongation in anaphase. Eg5 inhibition or deple-
tion halts mitotic progression in prometaphase (Kapoor et al.,
2000; Mayer et al., 1999; Sawin and Mitchison, 1995). However,
functional analysis of Eg5 is complicated by overlapping path-
ways that drive centrosome separation, spindle assembly and
spindle elongation; the aforementioned Mst2-hSav1-Nek2A
kinase module being a prime example. Additionally, it was
recently shown that upregulation of the kinesin-12 hKlp2/Kif15
can generate cells that divide independently of Eg5 (Raaijmakers
et al., 2012).
Thirty years ago, Sherline and Mascardo (1982) observed
that addition of epidermal growth factor (EGF) to cells induced
centrosome separation, however, the mechanisms behind
this interesting phenomenon were unclear. EGF is well known
to bind and activate ErbB-1 receptor tyrosine kinase, the
epidermal growth factor receptor (EGFR), which has crucial
roles in determining growth state and cancer development
(Hynes and MacDonald, 2009). Importantly, EGFR is known
to be mutated or differentially expressed in many tumor types
thus constitutes one of the prime targets in cancer therapy
(Klein and Levitzki, 2009). EGFR activates a number of intracel-
lular pathways through several signal transducers (Hackel et al.,
1999; Zwick et al., 1999). Although its potential in regulating cell
proliferation via the control of G1/S transition is well estab-
lished, whether EGFR signaling impacts upon mitosis is largely
unknown.
In this study, we found that EGF induces early centrosome
separation in S phase through activation of the Mst2-hSav1-
Nek2A kinase module. Addition of EGF stimulates premature
centrosome separation and drastically reduces the requirementlopmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier Inc. 229
Figure 1. EGF Addition Induces Premature Centrosome Separation
in S Phase
(A) HeLa cells were arrested in S phase and then treated with or without EGF
(100 ng/ml) for 4 hr in the presence of aphidicolin. Cells were then fixed and
stained for a- (green) and g-tubulin (red). DNA is stained in blue. Scale bar
represents 10 mm.
(B) Asynchronous (aphidicolin) or S phase arrested (+aphidicolin) HeLa cells
were incubated without (red bars) or with 50 ng/ml (blue bars) of EGF. The
percentage of cells with separated centrosomes was scored. Results are from
three independent experiments. n R 300 cells were counted in each case.
Data are presented as mean ± SD.
(C) HeLa cells arrested in S phase were treated with increasing concentrations
of EGF and scored for the percentage of cells with separated centrosomes.
Results are from two independent experiments. nR 150 cells were counted in
each case. Data are presented as mean ± SD.
(D) HeLa cells synchronized in S phase were kept untreated (red bar) or treated
with 50 ng/ml EGF (blue bars) for 4 hr in the presence of the indicated inhibitors.
Results are from three independent experiments. nR 150 cells were counted
in each case. Data are mean ± SD.
(E) HeLa cells were transfected with the indicated constructs and treated with
5 ng/ml of EGF. The percentage of cells with separated centrosomeswas scored
by indirect immunofluorescence.Results are fromtwo independent experiments.
nR 50 cells were counted in each case. Data are presented as mean ± SD.
(F) HeLa cells were synchronized in S phase and kept untreated (red bar) or
treated with indicated EGFR ligands (blue bars) for 4 hr. Epiregulin is depicted
as ER and Amphiregulin is shown as AR. Results are from two independent
experiments. nR 150 cells were counted in each case. Data are mean ± SD.
See also Figure S1.
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EGFR Signaling Regulates Centrosome Separationfor Eg5 in mitotic progression. Additionally, early centrosome
separation promotes a rapid mitotic progression with fewer er-
rors. The centrosomal response to EGFR signaling promotes230 Developmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier Inproliferation and survival of cells. Importantly, cell types vary
dramatically in their response to EGFmaking it possible to derive
selective strategies to interfere with mitotic progression of cells
with elevated EGFR signaling.
RESULTS
EGF Receptor Signaling Drives Premature Centrosome
Separation via Akt Activation
To gain insights into the mechanisms of EGF-induced centro-
some separation, we arrested HeLa cells in S phase and
incubated them with EGF. As reported previously (Sherline and
Mascardo, 1982), EGF addition rapidly induced centrosome
separation in S phase (Figure 1A; Figure S1A and S1B available
online). Importantly, EGF also triggered centrosome separation
in asynchronous cells (Figure 1B, aphidicolin), indicating that
perturbation of DNA replication is not required for EGF-induced
centrosome separation. Although 5 ng/ml EGF was sufficient
to induce centrosome separation, maximal separation was
achieved with 50 ng/ml EGF (Figure 1C).
EGF stimulates various signaling pathways through autophos-
phorylation of the EGF receptor (EGFR) (Normanno et al., 2006;
Zwick et al., 1999). We exploited small molecule inhibitors of
the major kinases of the EGFR signaling pathway to delineate
the signaling cascade that ultimately promotes centrosome
separation. Inhibition of EGFR signaling with the EGFR inhibitor
Gefitinib blocked EGF-induced centrosome separation (Fig-
ure 1D; EGFRi). Importantly, inhibition of signaling downstream
of EGFR with two different PI3K/Akt inhibitors (AktIV, PI3Ki),
but not inhibitors against MEK kinase and downstream MAPK
(MEKi, MAPKi), mTOR, PTEN phosphatase, or Raf kinase (RafIV,
V, and VI) blocked EGF-induced centrosome separation (Fig-
ure 1D). Consistently, overexpression of myristoylated, active
form of Akt (Myr-Akt) promoted centrosome separation whereas
B-Raf and K-Ras did not (Figure 1E). Myr-Akt induced centro-
some separation most efficiently when the cells were sensitized
with 5 ng/ml EGF. We therefore conclude that EGF induces
premature centrosome separation through activation of Akt of
the EGFR signaling pathway.
Next, we stimulated the EGFR signaling by the addition of
different ligands that are known to bind and activate the EGFR.
Addition of TGFa and Epiregulin (ER) had little effect on centro-
some separation whereas we observed an increased rate of
centrosome separation in cells treated with Amphiregulin (AR)
(Figure 1F). EGF family ligands trigger different biological out-
comes by stimulating the same receptor (Citri and Yarden,
2006; Wilson et al., 2009). Our results indicate that the down-
stream signals activated by EGF or AR initiate premature centro-
some separation.
EGF-Induced Centrosome Separation Requires
the Mst2-Nek2A Pathway
Two distinct pathways contribute to centrosome separation
during normal cell cycle progression. First, Nek2A initiates
centrosome separation in G2 through phosphorylation of the
linker proteins C-Nap1 and rootletin. This function of Nek2A is
stimulated by two components of the Hippo pathway, Mst2
and hSav1, and by the Polo-like kinase Plk1 (Mardin et al.,
2010, 2011). A second pathway relies on the kinesin Eg5, whichc.
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Figure 2. EGF Induces Centrosome Separation through the Mst2-hSav1-Nek2A Kinase Module
(A) HeLa cells were transfectedwith NSC (nonspecific control), Nek2, Mst1/2, or hSav1 siRNA oligos, arrested in S phase and either kept untreated or treatedwith
50 ng/ml EGF for four hours. Cells were then fixed and costained with a- and g-tubulin antibodies. Scale bar represents 10 mm. Insets show the magnified
centrosomes in each panel.
(B) Extracts of nonspecific control (NSC), Nek2, Mst1/2, or hSav1 siRNA-treated HeLa cells were analyzed by immunoblotting using GAPDH, hSav1, Mst1/2, and
Nek2 antibodies.
(C) Quantification of the analysis in (A). Results are from three independent experiments. nR 100 cells counted for each condition. Data are mean ± SD.
(D–I) HeLa cells were treated as in (A). Cells were then fixed and costained for g-tubulin and Nek2 (D), rootletin (F), or C-Nap1 (H) antibodies. Scale bar represents
10 mm. The intensity of centrosomal Nek2 (E), rootletin (G), and C-Nap1 signals (I) in cells from (D), (F), and (H) were measured. The average background intensity
was subtracted and the intensities were normalized to corresponding g-tubulin signals. Results are from three independent experiments. n > 30 cells were
analyzed for each condition. Box-and-whiskers plots: boxes show the upper and lower quartiles (25%–75%) with a line at the median, whiskers extend from the
10th to the 90th percentile and dots correspond to the outliers.
See also Figure S2.
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(Mardin et al., 2010). We sought to determine the role of Nek2A-
and Eg5-dependent pathways in EGF-induced premature
centrosome separation. Depletion of Nek2A, hSav1 or Mst2 by
siRNA significantly reduced the fraction of cells with separated
centrosomes upon EGF addition (Figures 2A–2C). In contrast, in-
hibition of Eg5 with S-Trityl-L-Cysteine (STLC) (Skoufias et al.,
2006) had no effect on EGF-induced centrosome separation
(Figure S2A). Moreover, EGF-induced centrosome separation
did not require the activity of the major mitotic kinases, including
Plk1 (Figure S2A) and was independent of other components of
the Hippo pathway (Figure S2B). These results suggest that EGF
promotes centrosome separation by activating the Nek2A ki-
nase pathway.
Interestingly, EGF-induced centrosome separation was not
affected by global inhibition of translation or transcription (Fig-
ure S2A, CHX, ActD, and S2C). Moreover, the protein levels ofDeveNek2A and Mst2 in S phase-arrested cells did not change upon
cell stimulation with EGF (Figure S2D). Because accumulation
of Nek2A at the centrosomes directly correlates with its
local activity (Mardin et al., 2010), we reasoned that an
enhancement in Nek2A recruitment to centrosomes might
trigger EGF-induced centrosome separation. Indirect immuno-
fluorescence of cells treated with EGF during S phase revealed
a significant increase in centrosome-associated Nek2A (Fig-
ures 2D and 2E; p < 0.006). Consistently, the levels of Nek2A
substrates at the centrosome, C-Nap1 and rootletin, were
significantly reduced upon EGF stimulation (Figures 2F–2I;
p < 0.006 and p < 0.0001 for C-Nap1 and rootletin, respec-
tively). Together, these results indicate that the EGF-induced
centrosome separation in S phase arises from stimulation of
the Mst2-hSav1-Nek2A pathway, which leads to the accumula-
tion of Nek2A at centrosomes where it promotes disassembly
of the centrosomal linker.lopmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier Inc. 231
Figure 3. EGF Reduces the Requirement of Eg5 during Mitosis
(A) HeLa cells were arrested in S phase, released into G2 with or without EGF
addition (50 ng/ml), and re-arrested in earlymitosis by 5 mMSTLC for 4 hr. Cells
were then fixed and stained with a- and g-tubulin antibodies. Scale bar rep-
resents 5 mm.
(B) Cells were treated as in (A) with 5 mM STLC and then incubated with the
indicated EGF concentrations. Cells were analyzed for their ability to form
bipolar spindles. Results are from three independent experiments. n > 100
cells were counted for each condition. Data are mean ± SD.
(C) Cells were treated with aphidicolin and with (blue bars) or without EGF
(50 ng/ml) (red bars) as in (A) followed by incubation with the indicated STLC
concentrations. Cells were then analyzed for their ability to form a bipolar
spindle. Results are from three independent experiments. n > 100 cells
counted for each condition. Data are mean ± SD.
(D) Still images taken from movies of HeLa cells stably expressing H2B-
mCherry. Cells were first arrested in S phase, released into G2 with or without
EGF (50 ng/ml) addition, and then imaged every 6 min in the presence of 5 mM
STLC. The percentage of cells that completed mitosis is indicated above the
Developmental Cell
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232 Developmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier InPremature Centrosome Separation Promotes
Eg5-Independent Bipolar Spindle Assembly
Upon disassembly of the centrosomal linker, Eg5 moves the
centrosomes apart to establish the bipolar spindle (Bruinsma
et al., 2012; Mardin et al., 2010; Mardin and Schiebel, 2012).
We examined the impact of EGF stimulation on bipolar spindle
assembly. Without additional EGF in the medium, inhibition of
Eg5 with STLC prevented bipolar spindle assembly and blocked
cell cycle progression in prometaphase (Figure 3A). Strikingly,
however, stimulation of cells with EGF allowed cells to assemble
bipolar spindles and progress through mitosis even in the pres-
ence of low Eg5 activity. The rate of progression through mitosis
in the presence of Eg5 inhibition was positively correlated with
the concentration of EGF (Figure 3B) and was observed even
when STLC concentrations as high as 20 mMwere used to block
Eg5 activity (Figure 3C). To exclude that EGF affects the
response of cells to STLC via upregulation of hKlp2/Kif15 or indi-
rectly, we first established that EGF did not influence cellular Eg5
or hKlp2/Kif15 levels (Figure S2D). In addition, we confirmed that
the inhibition of Eg5 with STLC was not affected by EGF stimu-
lation judged by the antibody staining of Eg5 in mitotic cells,
which relies on the direct correlation between Eg5 localization
and activity (Mardin et al., 2011; Sawin andMitchison, 1995) (Fig-
ure S3A). Moreover, when we depleted Eg5 by siRNA cells
assembled bipolar spindles only in the presence of EGF (Figures
S3B and S3C). These observations with fixed cells were
confirmed by live cell imaging of HeLa cells stably expressing
the histone H2B fused to mCherry as a chromatin marker (Fig-
ure 3D; Movie S1). Importantly, blocking centrosome separation
by codepletion of Mst2 and Nek2 prior to EGF stimulation did not
allow the cells to bypass the requirement of Eg5 upon EGF addi-
tion (Figures S4A and S4B). Together, these results indicate that
the activation of the EGFR signaling and the induction of prema-
ture centrosome separation reduces the requirement for Eg5
during bipolar spindle assembly.
The ability to form bipolar spindles in cells with reduced Eg5
activity prompted us to investigate whether an alternative motor
replaces Eg5 function in response to active EGFR signaling. The
kinesin hKlp2/Kif15 appears to take over bipolar spindle forma-
tion when Eg5 activity is compromised (Tanenbaum et al.,
2009; Vanneste et al., 2009). Analysis of cells in S phase with
active EGFR signaling revealed that centrosome separation
was independent of kinesin hKlp2/Kif15 as well as of dynein (Fig-
ure S4C). However, bipolar spindle assembly in EGF-stimulated
cells in the presence of STLC was efficiently blocked by deple-
tion of hKlp2/Kif15 (Figures 3E and 3F [live cell imaging] and
S4D and S4E [time course experiment]). We conclude that
hKlp2/Kif15 is required for Eg5-independent bipolar spindle as-
sembly in EGF-treated cells.panels. n > 50 cells analyzed for each condition. Asterisks indicate the dividing
cells in the sample.
(E) Extracts of nonspecific control (NSC), or hKlp2/Kif15 siRNA-treated HeLa
H2B-mCherry cells were analyzed by immunoblotting using GAPDH and
hKlp2/Kif15 antibodies.
(F) HeLa H2B-mCherry cells were transfected with NSC or hKlp2/Kif15 siRNA
oligos, arrested in S phase, released into G2 with or without EGF addition, and
imaged every 6 min in the presence of 5 mMSTLC. The cells were analyzed for
their ability to form bipolar spindles. Data are mean ± SD.
See also Figures S3 and S4 and Movie S1.
c.
Figure 4. EGFR Signaling Accelerates
Mitosis
(A) Still images from themovies of HeLa cells stably
expressing eGFP-LaminA and H2B-mCherry with
and without EGF addition following their release
from S phase arrest. Images are collected with a
time resolution of 3 min. Time spent during meta-
phase is indicated in minutes.
(B) Individual cell histories during metaphase pro-
gression. Each horizontal bar represents one cell.
The records are sorted according to the meta-
phase progression rate. n = 147 and 149 events
were analyzed for cells with (+EGF) and without
(EGF), respectively.
(C) Quantification of the events shown in (B).
Metaphase progression in single cells was auto-
matically measured after classification of cells by
cell cognition. Box-and-whiskers plots: boxes
show the upper and lower quartiles (25%–75%)
with a line at the median, whiskers extend to min-
imum and maximum values.
(D) HeLa cells expressing Mad2-LAP and H2B-
mCherry were incubated with or without EGF in
the presence of nocodazole. Cells were fixed and
stained with monoclonal Cenp-A antibodies. Scale
bar represents 5 mm.
(E) Ratiometric analysis of theMad2:Cenp-A signal
intensities of cells in (D). Signal intensities on
the kinetochores were analyzed automatically.
Box-and-whiskers plots: boxes show the upper
and lower quartiles (25%–75%) with a line at
the median, whiskers extend to minimum and
maximum values.
See also Figure S5 and Movie S2.
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during Metaphase
Next, we tested whether EGF-induced centrosome separation
has any beneficial impact upon mitotic progression in an unper-
turbed cell division. We followed HeLa cells stably expressing
EGFP-LaminA and H2B-mCherry (Mall et al., 2012) by live cell
imaging together with and without EGF addition following their
release from S phase arrest (Figure 4A). When centrosome
separation was promoted in S phase by EGF, timing of meta-
phase was decreased on average by 8 min (Figures 4B and
4C; Movie S2) meaning that duration of metaphase was reduced
by 44%. Interestingly, acceleration of mitosis in response to
EGF correlated with its impact upon centrosome separation as
codepletion of Mst2 and Nek2 neutralized the impact of EGF
addition (Figures S5A and S5B; Movie S3).
Given that the EGF addition causes the cells to align their
chromosomes faster on the metaphase plate, we asked whetherDevelopmental Cell 25, 229–the spindle assembly checkpoint (SAC)
is affected in EGF-treated cells. HeLa
cells expressing Mad2-LAP (Poser et al.,
2008) were released from the aphidicolin
block with or without EGF addition and
arrested in prometaphase with nocoda-
zole. Most kinetochores (labeled with
CENP-A antibodies) colocalized with the
SAC component Mad2. Ratiometric anal-ysis of the Mad2/CENP-A intensities of over 1,500 kinetochores
showed that Mad2 was equally recruited to kinetochores with
or without EGF addition (Figures 4D and 4E) that suggests
that the SAC is not affected by EGF (Chen et al., 1996; Waters
et al., 1998). This notion is consistent with the observation
that cells remained equally arrested in prometaphase when
they are challenged by different concentrations of nocodazole
together with or without EGF (Figure S5C).
EGFR Signaling Increases Fidelity of Chromosome
Segregation in Genetically Unstable Cells
Our results suggest that EGF accelerates mitosis possibly due to
premature separation of centrosomes. Previous studies have
suggested an impact of the timing of centrosome separation
on mitotic progression and fidelity (Indjeian and Murray, 2007;
Kaseda et al., 2012; Silkworth et al., 2012). In order to test the
effect of EGF-induced centrosome separation on mitotic fidelity,240, May 13, 2013 ª2013 Elsevier Inc. 233
Figure 5. EGFR Signaling Increases Fidelity of Chromosome Segre-
gation
(A) Representative images of different classes of mitotic defects that were
analyzed from movies in Figure 4A. Scale bar represents 5 mm. See also
Movie S3.
(B) Manual quantification of mitotic defects from movies of HeLa-eGFP-
LaminA/H2B-mCherry cells that were treated with or without EGF (50 ng/ml).
Movies of five independent experiments were analyzed. Data are mean ± SD.
(C) HeLa-eGFP-LaminA/H2B-mCherry cells were cultured in the presence or
absence of EGF for 6 days. For the last division, they were imaged by high
content screening microscopy and automatically scored for the formation of
the polylobed nuclei. In total, 5,800 cells for untreated samples and 3,600 cells
for EGF-treated samples were analyzed. Data are mean ± SD.
(D) HCT116 cells were incubated with (blue bars) or without (purple bars) EGF
for 6 days. Cells were then fixed and analyzed by FISH with four different
chromosome-specific centromere probes. Deviant fractions represent the
percentages of the cells deviating from the modal number (two for HCT116
cells for all the four chromosomes analyzed). n > 800 for all measurements.
Data are mean ± SD.
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movies shown in Figure 4A. Under our experimental conditions,
20% of HeLa-eGFP-LaminA/H2B-mCherry cells showed
various mitotic defects such as lagging chromosomes, chromo-
some bridges, and chromosome missegregation without EGF
addition (Figures 5A and 5B). Addition of EGF significantly
reduced these mitotic defects and increased the fidelity of
mitosis (Figure 5B).
We reasoned that the decrease in mitotic errors by EGF
should eventually lead to decreased genomic instability. In
order to investigate this we incubated HeLa-eGFP-LaminA/
H2B-mCherry cells for 6 days with and without EGF. During
the last division we imaged these cells by high content
screening microscopy and scored thousands of cells for the
formation of polylobed nuclei indicative of mitotic exit with
aberrant chromosome segregation (Neumann et al., 2010). A
significant reduction of polylobed nuclei was observed in cells
that were treated with EGF (Figure 5C). Thus, EGFR signaling
in HeLa cells does not only accelerate mitosis, it also promotes
the accuracy of chromosome segregation.234 Developmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier InUsing fluorescence in situ hybridization (FISH) we asked how
cells with a stable chromosome set segregate the chromosomes
in response to high levels of EGFR signaling. HCT116 cells
have a stable chromosome set (Lengauer et al., 1997) and
show intermediate sensitivity to EGF-induced centrosome
separation (2-fold increase in S phase centrosome separation
in response to EGF; Figure 6A). After culturing cells for 6 days
with and without EGF, interphase FISHwas used to analyze cells
for the rates of whole chromosome missegregation (Figure 5D).
Using four different chromosome-specific probes, we detected
no significant difference in chromosome missegregation rates
under these experimental conditions. In conclusion, EGFR
signaling promotes the fidelity of chromosome segregation in
genetically unstable cells and has little effect on chromosome
stability in cells that are genetically stable.
The Impact of EGF on Centrosome Separation Depends
on Basal EGFR Signaling
The timing of centrosome separation is highly variable between
cell lines (McHedlishvili et al., 2012; Toso et al., 2009). To deter-
mine whether the activity of the EGFR signaling pathway
accounts for this variation, we analyzed the degree of centro-
some separation and its dependency on the EGFR signaling in
several cancer cell lines of pancreatic (CAPAN-1 and AsPC-1),
mammary (MCF-7), renal (ACHN), bone (U2OS), colorectal
(HCT116), lung (NCl-H358 and NCl-H460), and cervical (HeLa)
origins, and in two untransformed cell lines (RPE-1 [retina] and
HPDE [pancreas]). We arrested all cells in S phase and deter-
mined the percentage of cells with separated centrosomes after
incubation with 1 to 100 ng/ml EGF. CAPAN and AsPC-1 cells
displayed particularly high levels of centrosome separation
even without EGF addition (55%–60% for CAPAN-1 and 35%–
40% for AsPC-1), which further increased in the presence of
EGF (Figure 6A). HeLa cells showed moderate centrosome
separation of 20%–25% in S phase in the absence of EGF
addition and responded well to EGF with 60%–70% of cells
displaying separated centrosomes. In contrast, the nontrans-
formed RPE-1 and HPDE cells had particularly low levels of
centrosome separation in S phase and both were refractory to
high concentrations of EGF.
This result prompted us to investigate whether there is any
correlation between the degree of centrosome separation and
EGFR signaling. We selected four cell lines displaying the full
spectrum of centrosome separation phenotypes (RPE-1, HeLa,
AsPC-1, and CAPAN-1) for further studies. We found that
CAPAN and AsPC-1 cells expressed particularly high levels
of the EGF receptor, which correlated with the high levels of
centrosome separation in S phase (Figures 6A and 6B). More-
over, we observed particularly high levels of centrosome-
associated Nek2 in EGF-responsive cell lines in contrast to
RPE-1 cells by quantitative immunofluorescence. EGF addition
enhanced Nek2 recruitment to centrosomes in all cell lines. In
RPE-1 cells this increase was moderate and remained below
the levels of Nek2 in the other cell lines (Figure 6C). It is likely
that the critical threshold that is needed to trigger centrosome
splitting was not exceeded in RPE-1 cells.
We next asked if we could alter the level of centrosome sepa-
ration in one of these cell lines by modifying the levels of EGFR
signaling. We approached this question from two differentc.
Figure 6. EGFR Signaling Induces Different Levels of Centrosome
Separation
(A) All cells were arrested in S phase by aphidicolin and the frequency of
centrosome separation was analyzed in the presence of increasing concen-
trations of EGF (1–100 ng/ml). n > 100 cells were counted for each condition.
Examples of separated and unseparated centrosomes with g-tubulin staining
(red) are shown.
(B) Asynchronous RPE-1, HeLa, AsPC-1, and CAPAN-1 cells were induced
with 50 ng/ml EGF. Cell extracts were analyzed after blotting with indicated
antibodies.
(C) RPE-1, HeLa, AsPC-1, and CAPAN-1 cells were arrested in S phase, and
then treated with or without EGF (50 ng/ml). Cells were stained with g-tubulin
and Nek2 antibodies and the centrosomal association of Nek2 was deter-
mined in relation to g-tubulin. Box-and-whiskers plots: boxes show the upper
and lower quartiles (25%–75%) with a line at the median, whiskers extend to
minimum and maximum values.
(D) CAPAN-1 and AsPC-1 cells were treated with or without Akt inhibitor IV and
arrested in S phase. Cells were then stained with g-tubulin antibodies and
scored for the number of cells with separated centrosomes. Data are
mean ± SD.
(E) RPE-1 cells were transfected with EGFR-eGFP for 18 hr while being ar-
rested in S phase by aphidicolin. Cells were then fixed and analyzed by indirect
immunofluorescence. The percentage of cells with separated centrosomes
was scored. Results are from three independent experiments. n R 30 cells
were counted in each case. Data are presented as mean ± SD.
(F) RPE-1, HeLa, AsPC-1, and CAPAN-1 cells were arrested in S phase,
released into G2with or without EGF addition (50 ng/ml), and treated with 5 mM
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Deveperspectives. First, we inhibited downstream EGFR signaling by
Akt inhibitor IV in AsPC-1 and CAPAN-1 cells that have high
levels of basal centrosome separation. Interestingly, this treat-
ment reduced centrosome separation in AsPC-1 and CAPAN-1
cells suggesting a direct involvement of high EGFR signaling in
centrosome separation (Figure 6D). Second, we overexpressed
EGFR in RPE-1 cells and found that the EGFR increased the per-
centage of S phase cells with separated centrosomes 2-fold
further supporting a direct effect of high EGFR signaling on
centrosome separation (Figure 6E). Taken together, the differ-
ences in centrosome separation efficiency between different
cell lines are at least in part a reflection of the basal activity of
the EGFR signaling pathway.
Our previous results suggested that the timing of centrosome
separation might have an impact on the requirement of Eg5
for spindle assembly. For this reason, we analyzed mitotic pro-
gression of RPE-1, HeLa, AsPC-1, and CAPAN-1 cells that are
released from S phase in the presence of 5 mM STLC together
with or without addition of EGF (Figure 6F). Similar to our previ-
ous observations, addition of EGF promoted bipolar spindle
formation in STLC-treated HeLa cells. In contrast, RPE-1 cells
failed to form bipolar spindles even when treated with EGF.
Importantly, 30%–50% of cells of the two pancreatic cell lines
formed bipolar spindles in the presence of 5 mM STLC even
without EGF addition. CAPAN-1 cells were more potent in bipo-
lar spindle formation than AsPC-1 cells even without addition
of EGF. This is consistent with the high level of EGFR expression
in CAPAN-1 cells (Figure 6B) and themore frequent separation of
centrosomes in S phase (Figure 6A) compared to AsPC-1 cells.
Thus, the level of centrosome separation in S phase determines
the requirement of Eg5 function for spindle formation.
We assessed the impact of EGF stimulation on mitotic pro-
gression in other cell lines. In synchronized RPE-1 H2B-mRFP
cells we found no statistically significant difference in the timing
ofmitotic progression with or without EGF (Figure 6G). EGF addi-
tion to CAPAN-1 cells did not accelerate mitotic progression
(from cell rounding to chromosome segregation), in line with
their high level of basal centrosome separation in S phase cells
prior to EGF addition. In contrast, mitotic progression of AsPC-
1 cells was accelerated by 10min in response to EGF (Figure 6G).
This value is consistent with the degree of centrosome separa-
tion in AsPC-1 cells following EGF stimulation. Together, these
data suggest that early centrosome separation by EGF
facilitates spindle assembly.
Cell Proliferation in Response to Changes in EGFR
Signaling and Eg5 Inhibition
The experiments described above raised the possibility that the
level of EGFR signaling might influence the overall response ofSTLC for 4 hr. Cells were then analyzed for their ability to form bipolar spindles.
Results are from three independent experiments. n > 50 cells counted for each
condition. Data are mean ± SD.
(G) Average time from chromosome condensation to anaphase (RPE-1 H2B-
RFP) or cell rounding to chromosome segregation (AsPC-1 andCAPAN-1) was
quantified for cells with and without EGF addition (50 ng/ml). Box-and-
whiskers plots: boxes show the upper and lower quartiles (25%–75%) with a
line at the median, whiskers extend to minimum and maximum values.
See also Figure S6.
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Figure 7. The Rates of Cell Proliferation and Survival in Cancer Cells
Vary in Response to Changes in EGFR Signaling and Eg5 Inhibition
(A) RPE-1, HeLa, AsPC-1, and CAPAN-1 cells were treated with or without
EGF (+/) and incubated in the presence of STLC (2.5 or 5 mM) for 3 days.
The metabolic activity of the cells was analyzed by the MTT assay and is
presented relative to the activity at the start of the experiment in each
case. The results are from three independent experiments. Data are
mean ± SD.
(B) RPE-1, HeLa, AsPC-1, and CAPAN-1 cells were treated with EGFR
kinase inhibitor Gefitinib (0 to 1 mM) and the Eg5 inhibitor STLC (0, 2.5, or
5 mM) for 3 days. The metabolic activity of the cells was analyzed by
the MTT assay and is normalized relative to the activity of untreated cells.
Heat maps are generated with GiTools software. For individual graphs see
Figure S6C.
(C) EGF induces centrosome separation during S phase through the Akt
branch of the signaling pathway. This leads to increased accumulation of
Nek2A at the centrosomes resulting in premature resolution of the centrosome
linker. During mitosis, this premature centrosome separation reduces the
requirement for Eg5 in bipolar spindle formation but renders mitosis reliant
upon the alternative motor hKlp2/Kif15. Different cell types respond differently
to EGF addition at both single-cell and population level. See Discussion for
details.
Developmental Cell
EGFR Signaling Regulates Centrosome Separation
236 Developmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier Incells to Eg5 inhibition. To address this, we followed cells for
3 days in the presence of STLC (2.5 or 5 mM) with or without
EGF treatment. Using an MTT assay to monitor metabolic
activity of the cells, we found that STLC reduced the viability of
HeLa cells over time; however, this inhibitory impact was
rescued by EGF addition. In contrast, EGF had no effect on
viability in response to STLC in RPE-1 cells. It is noteworthy
that the EGF nonresponding HPDE-1 cells (Figure 6A), which
have the same pancreatic origin as AsPC-1 and CAPAN-1 cells
also showed no change in viability during these measurements
(data not shown). In contrast, both AsPC-1 and CAPAN-1 cells
increase their metabolic activity over time even in the presence
of STLC. Importantly, this robust growth was further stimulated
by EGF addition (Figure 7A).
We confirmed these observations by an independent assay
that could simultaneously monitor cell proliferation and viability
(Guava Via Count) by using a mixture of two DNA binding
dyes: a membrane-permeable dye that stains all nucleated
cells and a membrane-impermeable dye that only stains
damaged cells thus giving a measure of the number of dying
cells within a culture (Figures S6A and S6B). Decrease in
viability of HeLa cells in response to STLC was suppressed
by EGF addition. RPE-1 cells showed no response to EGF
stimulation in terms of viability or proliferation, whereas both
viability and proliferation were increased by EGF addition to
AsPC-1 cells. These data support our previous observations
that STLC has distinct impacts on cell fate in different cell lines
in a manner that reflects the response of each cell line to EGF
stimulation.
We reasoned that if EGF addition allows some cells to prolifer-
ate with very low Eg5 activity, repressing the EGFR pathway
should sensitize these cells to Eg5 inhibition. In order to test
this idea, wemeasured the response of cell lines to the combina-
tion of Eg5 and EGFR inhibition. For this we used the EGFR
kinase inhibitor Gefitinib and the Eg5 inhibitor STLC, titrated
the concentration of both drugs and generated heat maps
based on the survival rate of the cells (Perez-Llamas and
Lopez-Bigas, 2011) (Figures 7B and S6C). RPE-1 cells were
not synergistically affected by the combination of Eg5 and
EGFR kinase inhibition (Figure 7B). However, most pronounced
in CAPAN-1 cells, neither Eg5 nor EGFR kinase inhibition alone
caused a strong inhibition of metabolic activity, but a com-
bination of both strikingly reduced the survival rate of these
cells (Figure 7B). We observed a dose-dependent decrease in
the survival of the cells, which suggests that the activity of the
EGFR signaling in context of centrosome separation is critical
for their response to Eg5 inhibition.
DISCUSSION
In this study, we demonstrate that stimulation of the EGFR
signaling pathway by EGF induces premature centrosome
separation in S phase through the activation of the Mst2-
hSav1-Nek2A module that targets Nek2A kinase to the centro-
somes. A direct consequence of our findings is that cells with
high EGFR activity bypass the requirement of Eg5 for mitosis.
This has important implications for cancer therapy because
cancer cells with high EGFR signaling are more susceptible
to combinatorial inhibition of EGFR and Eg5.c.
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Signaling Pathway
EGFR belongs to the ErbB family of receptor tyrosine kinases
and is frequently upregulated in cancer cells (Avraham and
Yarden, 2011; Klein and Levitzki, 2009). Although many complex
interactions exist within this signaling pathway (Citri and Yarden,
2006), we found that the Akt branch is required for EGF-induced
centrosome separation. In contrast, inhibitors against the lipid
phosphatase PTEN, Raf kinase, MEK kinases, and the MAPK,
or the growth controlling mTOR kinase had no effect on centro-
some separation in S phase.
The PI3K/Akt pathway is deregulated in many tumors due to
frequent mutations found in different components of the
pathway (Altomare and Testa, 2005; Testa and Tsichlis, 2005).
Presently, it is unclear whether Akt impacts directly on centro-
some separation; however, Akt can directly phosphorylate
Mst2 in serum-starved cells. In this context Akt phosphorylation
inhibits Mst2 activity (Romano et al., 2010). Addition of EGF
could also change the affinity of Mst2 for binding partners
thus directly or indirectly promoting the association of Mst2
and Nek2.
Why do the cells need to control the timing of centrosome
separation? Here we present evidence that the induction of
premature centrosome separation affects the way mitosis is
executed. First, addition of EGF and separation of the centro-
somes in S phase considerably reduced the duration of mitosis
particularly during metaphase alignment. This was not due to
abrogation of SAC function because the Mad2:CENP-A ratio
(Chen et al., 1996; Waters et al., 1998) was unaltered by EGF
addition and cells responded equally to nocodazole with or
without EGF. Most likely in cells that separate centrosomes
before nuclear envelope breakdown, opposing kinetochores
are captured faster by microtubules facilitating amphitelic
attachments. Consistent with this, it was recently reported that
HeLa cells that have separated centrosomes before nuclear
envelope breakdown execute mitosis faster than cells with
unseparated centrosomes (Kaseda et al., 2012). In addition,
the configuration of chromosomes around the centrosomes
during prometaphase promotes the formation of amphitelic
attachments by exposing kinetochores to the centrosomally
nucleated microtubules (Magidson et al., 2011). Similarly, we
propose that positioning the centrosomes on the opposite sides
of the nucleus prior tomitotic entry facilitates the formation of the
bipolar spindle.
Second, HeLa cells treated with EGF executed mitosis more
accurately than cells without EGF. This increase in precision is
most likely a reflection of the more efficient spindle assembly
pathway when centrosomes are separated ahead of nuclear
envelope breakdown. However, in genetically stable HCT116
cells, EGFR signaling had no detectable influence on chromo-
some segregation fidelity. Thus, EGF signaling probably only
shows its chromosome stabilizing function when the spindle
apparatus is defective. Therefore, EGFR signaling will have
benefits for chromosome segregation when mutations or unfa-
vorable growth conditions such as downregulation of motor pro-
teins or drug treatment favors chromosome missegregation.
During early tumorigenesis, somemutationsmay allow cells to
overcome mitotic blocks giving cells a growth advantage. One
example is the bypass of Eg5 motor activity for mitosis by theDeveupregulation of EGFR. Recently, it was demonstrated that over-
expression of hKlp2/Kif15 can bypass the requirement for Eg5
motor activity (Raaijmakers et al., 2012). Similarly, dissolution
of the centrosomal linker ahead of nuclear envelope breakdown
by EGF bypasses the need of Eg5 and hKlp2/Kif15 motor activity
becomes sufficient to drive chromosome segregation. This is
either because Eg5 motor activity is no longer required for sep-
aration of the centrosomal linker or the prometaphase spindle
assembly pathway has less force requirement, which makes
hKlp2/Kif15 sufficient to drive spindle assembly.
EGFR Activity Determines the Timing of Centrosome
Separation and the Manner of Mitotic Progression in
Cell Lines
While examining the fate of cells with different responses to EGF,
we found that EGF addition induced centrosome separation only
in a subset of cell lines.We detected a direct correlation between
the degree of S phase centrosome separation and the require-
ment for Eg5 for bipolar spindle formation and responsiveness
to EGF. We also observed a clear correlation between the
expression of EGFR in cells and the levels of centrosome sepa-
ration. Interestingly, overexpression of EGFR in RPE-1 cells trig-
gered S phase separation of centrosomes even without addition
of EGF. High basal levels of EGFR signaling therefore might
account for the ability of some cell lines to separate centrosomes
in S phase with low EGF concentrations.
On the basis of our observations, we partitioned the EGF
response of cells into three categories (Figure 7C). The first
group (e.g., RPE-1, HPDE) responded poorly to EGF and did
not separate their centrosomes in S phase. These cells could
not overcome Eg5 inhibition and EGF addition provided no
advantage during mitosis. The second group responded well
to EGF (e.g., HeLa and AsPC-1) and separated their centro-
somes in S phase. Consistently, EGF addition allowed these
cells to progress through mitosis despite Eg5 inhibition and pro-
vided a long-term advantage in proliferation and viability. The
third group (e.g., CAPAN-1) had particularly high basal levels of
centrosome separation in S phase. Therefore, addition of EGF
to these cells had very little impact on centrosome separation.
Yet these cells were able to progress through mitosis even in
the absence of EGF and presence of 5 mM STLC. We therefore
propose that targeting mitosis requires an understanding of the
EGF response of a particular cell type not only in the context of
G1/S transition but also mitotic progression.
Implications for Novel Combination Approaches to
Cancer Therapy
Great efforts have been put into the discovery of drugs that
target mitosis to arrest cell cycle progression and induce mitotic
catastrophe in cancer cells while causing minimal cytotoxicity to
normal dividing cells (Garnett et al., 2012). Spindle poisons such
as paclitaxel are commonly used as cancer therapeutics (Ris-
inger et al., 2009). By interfering with microtubule dynamics,
paclitaxel induces mitotic arrest and apoptosis; however, the
reliance of many nonmitotic processes, such as intracellular
transport in the CNS, upon microtubules means that global
targeting of microtubules has significant side effects and conse-
quent toxicity issues. Targeting the kinesin Eg5, which is
required for the formation of a bipolar spindle (Sawin et al.,lopmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier Inc. 237
Developmental Cell
EGFR Signaling Regulates Centrosome Separation1992; Whitehead and Rattner, 1998), has therefore been a prom-
ising alternative to generate drugs that interfere with themicrotu-
bule-related aspects of cell division while having no impact upon
nondividing tissues. However, this approach has displayed
limited benefits in clinical trials due to nonspecific effects of
high dose Eg5 inhibition (Gartner et al., 2005; Leizerman et al.,
2004; Skoufias et al., 2006). Similarly, with the clear exception
of female lung cancer, EGFR inhibitors as single therapeutic
agents have not proven very efficient for selective elimination
of tumor cells. In this study, we evaluated how activation of the
EGFR signaling pathway is critical for the execution of mitosis
and how it is differentially regulated in different cancer cell lines,
thus proposing an alternative way to combine targets in cancer
therapy. For this reason, multitargeted approaches based
upon the level of inherent EGF signaling within a particular tumor
type might be more attractive.
EXPERIMENTAL PROCEDURES
An extended version of the experimental procedures can be found in the
Supplemental Experimental Procedures.
Cell Lines and Treatments
The HeLa Kyoto cell line expressing H2B-mCherry and EGFP-LaminA were
provided by Iain W. Mattaj (EMBL, Heidelberg, Germany) (Mall et al., 2012).
The HeLa Kyoto cell line expressing mMad2-LAP BAC was provided by
Anthony A. Hyman (MPI, Dresden, Germany) (Poser et al., 2008). H2B-
mCherry was transfected into HeLa cells expressing mMad2-LAP BAC with
Fugene 6 (Roche) according to the instructions of the manufacturer. A clone
stably expressing H2B-mCherry was isolated by selection with 0.5 mg/ml
Puromycin (Calbiochem), HeLaWT, U2OS, ACHN, andMCF7 cells were main-
tained in DMEM medium. hTERT RPE-1 and RPE-1-H2B-mRFP cells were
grown in DMEM F-12 medium, HCT116 cells in McCoy and CAPAN-1,
AsPC-1 cells were grown in IMDM cells, and NCl358 and NCl460 cells in
RPMI medium supplemented with heat inactivated 10% fetal bovine serum
and 2 mM glutamine. HPDE cells were maintained in Keratinocyte SFM me-
dium supplemented with at 37C in a humidified atmosphere with 5% CO2.
For specific drug treatments, see Supplemental Experimental Procedures.
Imaging
Imaging on most indirect immunofluorescence samples was performed at
25C on a DeltaVision RT system (Applied Precision) with an Olympus IX71
microscope equipped with FITC, TRITC and Cy5 filters (Chroma Technology),
a plan-Apo 1003 NA 1.4 and 603 NA 1.4 oil immersion objective (Olympus), a
CoolSNAP HQ camera (Photometrics), a temperature controller (Precision
Control), and Softworx software (Applied Precision).
For live cell imaging experiments shown in Figures 3D, 6G, and S5A, cells
were seeded on Hi-Q4 culture dish (Nikon). Experiments were performed
either on anOlympus IX81microscope equippedwith GFP andmCherry filters,
a UPLSAPO 203/0.75 Air objective, a Hamamatsu ORCA-R2 camera and tem-
perature controller or on a Biostation system (Nikon) equipped with GFP and
mCherry filters, 203 0.5 NA and 403 0.8 NA air objectives and DS-2MBWc
camera. For the experiments shown in Figures 3D, images are acquired every
6 min and the prometaphase arrested cells were scored versus the cells that
go through mitosis. For experiments shown in Figures 6G and S5A, images
were acquired every 2 min, and the timing from the nuclear envelope break-
down to chromosome segregation was determined and plotted.
For the live cell imaging experiments shown in Figures 4, 5A, and 5B, the
cells were imaged with the Zen 2010 Software on a Zeiss 780 confocal micro-
scope with a 633 PlanApochromat oil objective, NA 1.4 (Carl Zeiss) and an in-
house temperature controller. We used 6 z stacks with 2.65 mm intervals for
each position. Images were acquired with 3 min time resolution. For experi-
ments shown in Figure S5C, images were acquired every 5 min.
For the live cell imaging experiments demonstrated in Figure 5C, images
were acquired with an automated epifluorescence microscope (IX-81;238 Developmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier InOlympus) equipped with Plan103, NA 0.4; Olympus objective, GFP and
mCherry filters and a ScanR software. An image-based autofocusing routine
was used to focus on the maximum number of interphase cells (scoring size,
intensity, contrast) in a field of view. The focus z coordinates of the positions
were saved during the first round of imaging and applied to the other time
points.
Fluorescence Intensity Measurements
ImageJ (http://rsb.info.nih.gov/ij) was used to define an area around the
centrosome and near the centrosome (background), and to measure the
mean fluorescence intensity. Unsplit centrosomes were measured together,
whereas split centrosomes were measured separately. Average of back-
ground intensities were subtracted from measurements in each channel.
Signal intensity of unsplit pairs was divided by 2 to get the average intensity
at each centrosome. Signal intensities were corrected for corresponding
g-tubulin signals. In order to measure Nek2 intensity from different cell lines,
images from one data set were acquired at the same day and exposure times
were set equal between different samples. To measure distances between
centrosomes, two poles were identified (according to g-tubulin or centrin
signals) from raw data and distance was determined by ImageJ. The centro-
somes were considered as ‘‘separated’’ when the distance between the two
poles was >2 mm.
Quantitative Immunofluorescence
ForMad2 localization studies that is shown in Figures 4D and 4Ewe used a cell
line expressing H2B-mCherry and the mMad2 tagged with a modified version
of the localization and affinity purification (LAP)-tag (Cheeseman and Desai,
2005) at its last exon, integrated in a bacterial artificial chromosome (BAC)
(mMad2-LAP BAC) (Poser et al., 2008). Images of HeLa cells expressing
H2B-mCherry and mMad2-LAP BAC were acquired on a Zeiss LSM780
confocal microscope with a 633 1.4 NA oil objective (Carl Zeiss).
To measure mMad2 expression levels at kinetochore in 3D images, the
nuclear shape after segmentation of the H2B-mCherry channel created a
nuclear mask in which mMad2-LAP and anti-CENP-A mean intensity were
measured. The overlapped CENP-A signals in 9 pixels circles were automati-
cally excluded from the measurement. To correct for intensity variability of
mMad2-LAP, we normalized mMAd2-LAP signal to the kinetochore signal of
the CENP-A antibody. Segmentation and intensity measurements were car-
ried out automatically by an in-house developed Fiji routine.
Automated Quantitative Phenotypic Analysis
Automated quantitative analysis of dividing H2B-mCherry and eGFP-laminA
expressing cells was used to monitor for mitotic progression in single cells.
For this, nuclei were detected in the H2B-mCherry channel and classified as
previously described (Held et al., 2010; Walter et al., 2010). For classification,
we defined nine morphological classes: interphase, prophase, prometaphase,
metaphase, early anaphase, late anaphase, telophase, cell death, and poly-
lobed nuclei. The training set contained 946 manually labeled nuclei, which
were detected with an overall accuracy of more than 90.0%. Cells were
tracked with a constrained nearest-neighbor tracking procedure, and mitotic
onset was detected as interphase–prophase or interphase–prometaphase
transition. To reduce the effect of classification errors on phase length mea-
surements, classification results were corrected with hidden Markov models
(Held et al., 2010). Triplicates with each at least 40mitotic events per condition
were analyzed. For each replicate, metaphase duration was automatically
measured.
Cell Proliferation and Growth Assays
The MTT assay was used to quantify cytotoxicity. For the growth and viability
tests, cells were analyzed using a small desktop Guava Personal Cytometer
with Guava ViaCount software (Milipore). Viable populations were gated based
on forward and side scatters.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, three movies, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2013.03.012.c.
Developmental Cell
EGFR Signaling Regulates Centrosome SeparationACKNOWLEDGMENTS
We thank Stefanie Heinze for excellent technical support. We also thank
J. Bulkescher for the help with High Content Screening microscopy. Dr. O.
Sahin is acknowledged for the gift of EGFR and MEK kinase inhibitors, Dr. T.
Mayer for siRNA oligonucleotides directed against hKlp2/Kif15, Drs. I. Vernos
and R. Medema for antibodies against hKlp2/Kif15, Dr. C. Pritchard for lung
cancer cell lines, and Dr. M. Martins for the myr-Akt construct. We thank
Y. Zhang and Dr. N. Giese for their generous help in MTT and Guava assays
and F.G. Agircan and B. Cerikan for help in tissue culture. We thank Drs. I.
Hagan and A. Khmelinskii for critical comments to the manuscript. We are
grateful to Dr. J.O. Korbel for his support during the revision process. This
work was supported by financial support of the SFB1036. A.M.F. acknowl-
edges support from the Association of International Cancer Research
(AICR), the Wellcome Trust, and Cancer Research UK.
Received: August 17, 2012
Revised: January 31, 2013
Accepted: March 18, 2013
Published: May 2, 2013
REFERENCES
Altomare, D.A., and Testa, J.R. (2005). Perturbations of the AKT signaling
pathway in human cancer. Oncogene 24, 7455–7464.
Avraham, R., and Yarden, Y. (2011). Feedback regulation of EGFR signalling:
decision making by early and delayed loops. Nat. Rev. Mol. Cell Biol. 12,
104–117.
Bruinsma, W., Raaijmakers, J.A., and Medema, R.H. (2012). Switching Polo-
like kinase-1 on and off in time and space. Trends Biochem. Sci. 37, 534–542.
Cheeseman, I.M., and Desai, A. (2005). A combined approach for the localiza-
tion and tandem affinity purification of protein complexes frommetazoans. Sci.
STKE 2005, pl1.
Chen, R.H., Waters, J.C., Salmon, E.D., and Murray, A.W. (1996). Association
of spindle assembly checkpoint component XMAD2 with unattached kineto-
chores. Science 274, 242–246.
Citri, A., and Yarden, Y. (2006). EGF-ERBB signalling: towards the systems
level. Nat. Rev. Mol. Cell Biol. 7, 505–516.
Garnett, M.J., Edelman, E.J., Heidorn, S.J., Greenman, C.D., Dastur, A., Lau,
K.W., Greninger, P., Thompson, I.R., Luo, X., Soares, J., et al. (2012).
Systematic identification of genomicmarkers of drug sensitivity in cancer cells.
Nature 483, 570–575.
Gartner, M., Sunder-Plassmann, N., Seiler, J., Utz, M., Vernos, I., Surrey, T.,
and Giannis, A. (2005). Development and biological evaluation of potent and
specific inhibitors of mitotic Kinesin Eg5. ChemBioChem 6, 1173–1177.
Hackel, P.O., Zwick, E., Prenzel, N., and Ullrich, A. (1999). Epidermal growth
factor receptors: critical mediators of multiple receptor pathways. Curr.
Opin. Cell Biol. 11, 184–189.
Held, M., Schmitz, M.H., Fischer, B., Walter, T., Neumann, B., Olma, M.H.,
Peter, M., Ellenberg, J., and Gerlich, D.W. (2010). CellCognition: time-resolved
phenotype annotation in high-throughput live cell imaging. Nat. Methods 7,
747–754.
Hynes, N.E., and MacDonald, G. (2009). ErbB receptors and signaling path-
ways in cancer. Curr. Opin. Cell Biol. 21, 177–184.
Indjeian, V.B., and Murray, A.W. (2007). Budding yeast mitotic chromosomes
have an intrinsic bias to biorient on the spindle. Curr. Biol. 17, 1837–1846.
Kapoor, T.M., Mayer, T.U., Coughlin, M.L., and Mitchison, T.J. (2000). Probing
spindle assembly mechanisms with monastrol, a small molecule inhibitor of
the mitotic kinesin, Eg5. J. Cell Biol. 150, 975–988.
Kaseda, K., McAinsh, A.D., and Cross, R.A. (2012). Dual pathway spindle
assembly increases both the speed and the fidelity of mitosis. Biol. Open 1,
12–18.
Klein, S., and Levitzki, A. (2009). Targeting the EGFR and the PKB pathway in
cancer. Curr. Opin. Cell Biol. 21, 185–193.DeveLeizerman, I., Avunie-Masala, R., Elkabets, M., Fich, A., and Gheber, L. (2004).
Differential effects of monastrol in two human cell lines. Cell. Mol. Life Sci. 61,
2060–2070.
Lengauer, C., Kinzler, K.W., and Vogelstein, B. (1997). Genetic instability in
colorectal cancers. Nature 386, 623–627.
Magidson, V., O’Connell, C.B., Loncarek, J., Paul, R., Mogilner, A., and
Khodjakov, A. (2011). The spatial arrangement of chromosomes during prom-
etaphase facilitates spindle assembly. Cell 146, 555–567.
Mall, M., Walter, T., Gorja´na´cz, M., Davidson, I.F., Nga Ly-Hartig, T.B.,
Ellenberg, J., and Mattaj, I.W. (2012). Mitotic lamin disassembly is triggered
by lipid-mediated signaling. J. Cell Biol. 198, 981–990.
Mardin, B.R., and Schiebel, E. (2012). Breaking the ties that bind: new
advances in centrosome biology. J. Cell Biol. 197, 11–18.
Mardin, B.R., Lange, C., Baxter, J.E., Hardy, T., Scholz, S.R., Fry, A.M., and
Schiebel, E. (2010). Components of the Hippo pathway cooperate with Nek2
kinase to regulate centrosome disjunction. Nat. Cell Biol. 12, 1166–1176.
Mardin, B.R., Agircan, F.G., Lange, C., and Schiebel, E. (2011). Plk1 controls
the Nek2A-PP1g antagonism in centrosome disjunction. Curr. Biol. 21,
1145–1151.
Mayer, T.U., Kapoor, T.M., Haggarty, S.J., King, R.W., Schreiber, S.L., and
Mitchison, T.J. (1999). Small molecule inhibitor of mitotic spindle bipolarity
identified in a phenotype-based screen. Science 286, 971–974.
McHedlishvili, N., Wieser, S., Holtackers, R., Mouysset, J., Belwal, M., Amaro,
A.C., and Meraldi, P. (2012). Kinetochores accelerate centrosome separation
to ensure faithful chromosome segregation. J. Cell Sci. 125, 906–918.
Neumann, B., Walter, T., He´riche´, J.K., Bulkescher, J., Erfle, H., Conrad, C.,
Rogers, P., Poser, I., Held, M., Liebel, U., et al. (2010). Phenotypic profiling
of the human genome by time-lapse microscopy reveals cell division genes.
Nature 464, 721–727.
Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M.R.,
Carotenuto, A., De Feo, G., Caponigro, F., and Salomon, D.S. (2006).
Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366, 2–16.
Perez-Llamas, C., and Lopez-Bigas, N. (2011). Gitools: analysis and visualisa-
tion of genomic data using interactive heat-maps. PLoS ONE 6, e19541.
Poser, I., Sarov, M., Hutchins, J.R., He´riche´, J.K., Toyoda, Y., Pozniakovsky,
A., Weigl, D., Nitzsche, A., Hegemann, B., Bird, A.W., et al. (2008). BAC
TransgeneOmics: a high-throughputmethod for exploration of protein function
in mammals. Nat. Methods 5, 409–415.
Raaijmakers, J.A., van Heesbeen, R.G., Meaders, J.L., Geers, E.F.,
Fernandez-Garcia, B., Medema, R.H., and Tanenbaum, M.E. (2012). Nuclear
envelope-associated dynein drives prophase centrosome separation and
enables Eg5-independent bipolar spindle formation. EMBO J. 31, 4179–4190.
Risinger, A.L., Giles, F.J., and Mooberry, S.L. (2009). Microtubule dynamics as
a target in oncology. Cancer Treat. Rev. 35, 255–261.
Romano, D., Matallanas, D., Weitsman, G., Preisinger, C., Ng, T., and Kolch,
W. (2010). Proapoptotic kinaseMST2 coordinates signaling crosstalk between
RASSF1A, Raf-1, and Akt. Cancer Res. 70, 1195–1203.
Sawin, K.E., and Mitchison, T.J. (1995). Mutations in the kinesin-like protein
Eg5 disrupting localization to the mitotic spindle. Proc. Natl. Acad. Sci. USA
92, 4289–4293.
Sawin, K.E., LeGuellec, K., Philippe, M., and Mitchison, T.J. (1992). Mitotic
spindle organization by a plus-end-directed microtubule motor. Nature 359,
540–543.
Sherline, P., and Mascardo, R.N. (1982). Epidermal growth factor induces
rapid centrosomal separation in HeLa and 3T3 cells. J. Cell Biol. 93, 507–512.
Silkworth, W.T., Nardi, I.K., Paul, R., Mogilner, A., and Cimini, D. (2012). Timing
of centrosome separation is important for accurate chromosome segregation.
Mol. Biol. Cell 23, 401–411.
Skoufias, D.A., DeBonis, S., Saoudi, Y., Lebeau, L., Crevel, I., Cross, R.,Wade,
R.H., Hackney, D.D., and Kozielski, F. (2006). S-trityl-L-cysteine is a reversible,
tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic
progression. J. Biol. Chem. 281, 17559–17569.lopmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier Inc. 239
Developmental Cell
EGFR Signaling Regulates Centrosome SeparationTanenbaum, M.E., and Medema, R.H. (2010). Mechanisms of centrosome
separation and bipolar spindle assembly. Dev. Cell 19, 797–806.
Tanenbaum, M.E., Macurek, L., Janssen, A., Geers, E.F., Alvarez-Ferna´ndez,
M., and Medema, R.H. (2009). Kif15 cooperates with eg5 to promote bipolar
spindle assembly. Curr. Biol. 19, 1703–1711.
Testa, J.R., and Tsichlis, P.N. (2005). AKT signaling in normal and malignant
cells. Oncogene 24, 7391–7393.
Toso, A., Winter, J.R., Garrod, A.J., Amaro, A.C., Meraldi, P., and McAinsh,
A.D. (2009). Kinetochore-generated pushing forces separate centrosomes
during bipolar spindle assembly. J. Cell Biol. 184, 365–372.
Vanneste, D., Takagi, M., Imamoto, N., and Vernos, I. (2009). The role of Hklp2
in the stabilization and maintenance of spindle bipolarity. Curr. Biol. 19, 1712–
1717.
Walczak, C.E., and Heald, R. (2008). Mechanisms of mitotic spindle assembly
and function. Int. Rev. Cytol. 265, 111–158.240 Developmental Cell 25, 229–240, May 13, 2013 ª2013 Elsevier InWalter, T., Held, M., Neumann, B., He´riche´, J.K., Conrad, C., Pepperkok, R.,
and Ellenberg, J. (2010). Automatic identification and clustering of chromo-
some phenotypes in a genome wide RNAi screen by time-lapse imaging.
J. Struct. Biol. 170, 1–9.
Waters, J.C., Chen, R.H., Murray, A.W., and Salmon, E.D. (1998). Localization
of Mad2 to kinetochores depends on microtubule attachment, not tension.
J. Cell Biol. 141, 1181–1191.
Whitehead, C.M., and Rattner, J.B. (1998). Expanding the role of HsEg5 within
the mitotic and post-mitotic phases of the cell cycle. J. Cell Sci. 111, 2551–
2561.
Wilson, K.J., Gilmore, J.L., Foley, J., Lemmon, M.A., and Riese, D.J., 2nd.
(2009). Functional selectivity of EGF family peptide growth factors: implica-
tions for cancer. Pharmacol. Ther. 122, 1–8.
Zwick, E., Hackel, P.O., Prenzel, N., and Ullrich, A. (1999). The EGF receptor as
central transducer of heterologous signalling systems. Trends Pharmacol. Sci.
20, 408–412.c.
